Quetiapine (Seroquel): Uses, Dosage, Side Effects, Weight Gain & Safety

What It's Used For

Quetiapine (Seroquel) is used in psychiatry for schizophrenia and bipolar disorder, and it can be used as an add-on for major depression when antidepressants aren’t enough. Clinically, it’s also sometimes used off-label for severe anxiety or insomnia—but that’s usually reserved for situations where the psychiatric context makes sense and the benefits outweigh the very real tradeoffs (sedation, metabolic effects, dizziness).

Primary Indications

Schizophrenia: Helps reduce hallucinations, delusions, paranoia, and agitationBipolar disorder: Acute mania/mixed episodes, bipolar depression, and maintenance depending on the plan and formulationMajor depression (MDD): Add-on treatment (especially XR) when an antidepressant alone isn’t doing the job

Off-Label Uses

Generalized anxiety disorder (late-line, specialist setting)Insomnia when there’s a clear psychiatric comorbidity (not as a first-choice sleep med)PTSD-related hyperarousal/sleep issues (typically adjunctive)Treatment-resistant OCD augmentationICU delirium-related agitation (short-term adjunct when needed)Parkinson disease psychosis (low-dose strategy under specialist guidance)Severe agitation/aggression with dementia (short-term adjunct only; high-risk population; not approved)

How Fast It Works

Quetiapine has two timelines: sedation can show up fast, while the real psychiatric benefits typically build over days to weeks depending on what you’re treating and the dose you’re using.

Hours to first doses

Sedation and dizziness can show up quickly (especially at bedtime dosing)

Days

Mania/agitation may start improving within days for some people as doses ramp

~1 week

Bipolar depression or depression augmentation can show early improvement for some, with continued gains over weeks

1–2 weeks

Schizophrenia symptoms may start improving, with fuller response often taking 4–6 weeks

Half-life

Quetiapine ~6–7 hours; active metabolite norquetiapine ~12 hours (helps explain why effects can carry into the next day for some people)

Safe Discontinuation

Quetiapine isn’t a “stop it suddenly” medication for most people—especially after long-term use. If you stop abruptly, you can get withdrawal-like symptoms and rebound insomnia/anxiety, and your underlying condition can flare. If you’re stopping because of a serious adverse effect, switching strategies may matter more than taper speed.

Key Points

If you’ve been off quetiapine for more than a week, many patients need re-titration rather than jumping back to the old dose.
Withdrawal/rebound symptoms can include agitation, anxiety, insomnia, sweating, GI symptoms, irritability, restlessness, tremor, and return of psychosis or mood symptoms.
General approach: Gradual dose reduction over weeks to months, tailored to diagnosis, duration of treatment, relapse risk, and side effects.
In chronic psychotic or bipolar disorders, clinicians often plan a switch (cross-titration or overlap-and-taper) rather than a hard stop.
If stopping due to severe adverse effects (like suspected NMS, severe liver injury, serious arrhythmia risk), urgent medical guidance is required and the plan may differ.

Dosing Information

Adult Dosing

schizophrenia ir initial: 50 mg/day PO in 1–2 divided doses (some first-episode or sensitive patients: 12.5 mg PO BID)

schizophrenia ir titration: Increase by 25–50 mg increments every ≥2 days based on response/tolerability

schizophrenia ir typical: 400–800 mg/day PO in 1–3 divided doses

schizophrenia ir max: 800 mg/day PO

schizophrenia xr initial: 300 mg PO once daily in the evening (empty stomach or light meal ≤300 calories)

schizophrenia xr titration: Increase by up to 300 mg/day every ≥1 day based on response/tolerability

schizophrenia xr typical: 400–800 mg PO once daily

schizophrenia xr max: 800 mg PO once daily

bipolar mania ir initial: 100–200 mg PO once daily at bedtime or in 2 divided doses on day 1

bipolar mania ir titration: Increase by 100 mg/day until 400 mg/day by day 4; thereafter increase by ≤200 mg/day as needed

bipolar mania ir max: 800 mg/day PO (some specialist use higher in select cases, with higher risk tradeoffs)

bipolar mania xr initial: 300 mg PO once daily on day 1; 600 mg PO once daily on day 2

bipolar mania xr titration: Adjust based on response/tolerability after day 2

bipolar mania xr max: 800 mg PO once daily (some specialist use higher in select cases, with higher risk tradeoffs)

bipolar depression bedtime initial: 50 mg PO once daily at bedtime

bipolar depression bedtime titration: Increase to 100 mg at bedtime on day 2; then increase by 50–100 mg/day to target

bipolar depression bedtime target: 300 mg PO once daily at bedtime by day 4–7

bipolar depression bedtime max: 300 mg/day (higher doses sometimes used clinically for select patients, but evidence for added benefit above 300 mg is limited)

mdd adjunct initial: 50 mg/day PO on days 1–2

mdd adjunct titration: Increase to 150 mg/day on day 3 (IR in 1–3 divided doses; XR once daily)

mdd adjunct typical: 150–300 mg/day PO (IR in 1–3 divided doses; XR once daily)

anxiety initial: 25 mg (IR only) to 50 mg PO once daily

anxiety titration: Increase gradually every ≥7 days based on response/tolerability

anxiety typical: 50–200 mg/day PO (IR 1–3 times daily; XR once daily)

anxiety max: 300 mg/day PO

sleep initial: IR: 25–100 mg PO at bedtime; XR: 50 mg PO at bedtime

sleep titration: XR may increase to 150 mg at bedtime by as early as day 3 and 300 mg by as early as day 5 if needed and tolerated

agitation delirium icu initial: 50 mg PO BID; in sensitive patients, some experts start 12.5 mg PO BID or 25–50 mg PO at bedtime

agitation delirium icu titration: Increase in 100 mg/day increments at intervals ≥1 day based on response/tolerability (or slower in smaller increments for sensitive patients)

agitation delirium icu max: 400 mg/day PO

dementia agitation psychosis short term initial: 25 mg PO at bedtime

dementia agitation psychosis short term titration: Increase gradually (example: weekly) based on response/tolerability

dementia agitation psychosis short term max: 75 mg PO BID

hepatic cirrhosis ir initial: 25 mg PO once daily; increase in 25–50 mg increments based on response/tolerability (divide into 1–3 doses as needed)

hepatic cirrhosis xr initial: 50 mg PO once daily; increase by 50 mg/day until effective dose achieved (XR not recommended for initial dosing in quetiapine-naive cirrhosis patients)

hepatic severe: Avoid use in severe hepatic impairment (example: Child-Turcotte-Pugh class C)

renal: No dosage adjustment needed for kidney impairment (including dialysis/CRRT scenarios in typical guidance)

older adults general: Use lower end of adult dosing and titrate slowly; avoid for behavioral symptoms of dementia/delirium unless nonpharmacologic options failed and risk of harm is high

Simple Explanation

At lower doses, quetiapine often acts mainly as a strong sedating/calming agent (helpful for sleep but can cause next-day grogginess). For bipolar disorder and schizophrenia, doses are typically higher and titrated deliberately to balance symptom control with side effects. IR can be split across the day; XR is usually once daily and should be swallowed whole.

Available Formulations

Immediate-release tablets (Seroquel / generic): 25 mg, 50 mg, 100 mg, 200 mg, 300 mg, 400 mg
Extended-release 24-hour tablets (Seroquel XR / generic): 50 mg, 150 mg, 200 mg, 300 mg, 400 mg

Critical Safety Information

Not approved for dementia-related psychosis. Antipsychotics increase mortality risk in older adults with dementia-related psychosis.

→If you’re over 65 with dementia-related psychosis, this medication is not approved and carries increased death risk—this is a big deal and should trigger a serious risk/benefit discussion.
→Expect sleepiness and dizziness early on—don’t drive or operate machinery until you know how you react.
→Stand up slowly. If you’re getting lightheaded or faint, tell your prescriber—dose and titration speed matter.
→Track weight and appetite. If hunger ramps up, that’s not “in your head”—it’s a known effect.
→Ask about baseline labs (glucose/A1c, lipids) and follow-up timing before you start.
→Report chest pounding, fainting, severe palpitations, or anything that feels like an abnormal rhythm—especially if you have heart risk factors.
→If you develop high fever, severe stiffness, confusion, or severe sweating/shaking—get emergency care (possible NMS).
→If mood worsens, agitation increases, or suicidal thoughts appear—contact your prescriber urgently. Families/caregivers should help monitor early in treatment.

Side Effects

Most common issues are sedation, dizziness/orthostatic hypotension, dry mouth/constipation, and metabolic changes (weight gain, lipids, glucose). Movement side effects can happen but are usually less prominent than with many other antipsychotics.

Common Things People Notice

Sleepiness or feeling sedated (especially early, and at night-dosed regimens)
Dizziness when standing up (orthostatic hypotension) and possible fainting
Increased appetite and weight gain
Changes in cholesterol/triglycerides and blood sugar
Dry mouth and constipation
Brain fog or slowed thinking (especially if dose is too high for your goal)
Restlessness/akathisia or tremor (less common, but can be very uncomfortable)

Common Side Effects

18% to 57% (reported ranges vary by study/population and dose)

Sedation / Drowsiness— This is one of the most noticeable effects. It can be helpful if sleep is part of the problem—but if you’re using it for mood/psychosis and feel flattened or foggy, the dose/timing may need adjusting.

2% to 7% in adults; higher rates reported in some older-adult data

Orthostatic Hypotension / Dizziness— Lightheadedness is most common in the first days of starting or after dose increases. Hydration, slower titration, and reviewing other blood-pressure-lowering meds can help.

Up to 9% to 44% (varies by age group and reporting source)

Dry Mouth (Xerostomia)— Dry mouth can be annoying and can increase dental risk. Water, sugar-free gum, and dental hygiene matter more than people think.

Weight gain reported 4% to 23% (significant gain possible over time)

Weight Gain / Increased Appetite— This can happen fast and can be dramatic for some people. If weight is climbing early, it’s worth intervening early (nutrition plan, activity, and sometimes medication strategy changes).

Triglycerides 8% to 28%; hypercholesterolemia 7% to 18%; hyperglycemia reported

Metabolic changes (lipids/glucose)— Even if you feel fine, labs can shift. That’s why baseline and follow-up monitoring is part of responsible prescribing.

2% to 10%

Constipation— Dose-related anticholinergic effects can contribute. Constipation can get severe if ignored—bring it up early so it’s manageable.

Serious side effects

Increased risk of death in older adults with dementia-related psychosis (class warning)
Neuroleptic malignant syndrome (rare): fever, rigidity, altered mental status, autonomic instability—EMERGENCY
Severe metabolic complications (rare but real): new-onset diabetes, diabetic ketoacidosis, severe hypertriglyceridemia, pancreatitis
QT prolongation and rare torsades de pointes (usually overdose or multiple risk factors): palpitations, syncope—urgent evaluation
Severe hypotension/syncope and falls, especially in older adults or during rapid titration
Blood dyscrasias (rare): leukopenia, neutropenia, thrombocytopenia; higher concern with low baseline counts or prior history
Hepatotoxicity (rare severe injury): jaundice, dark urine, severe fatigue; stop and evaluate
Tardive dyskinesia (risk increases with duration and total exposure): abnormal involuntary movements
Angioedema/hypersensitivity (rare): facial/lip/tongue swelling—EMERGENCY
Temperature dysregulation (rare): heat stroke risk in heat/exertion; reported hypothermia cases

Critical Drug Interactions

Quetiapine is primarily metabolized by CYP3A4. Interactions and additive side effects (sedation, low blood pressure, QTc effects) are the big practical issues.

With: Strong CYP3A4 inhibitors (example: certain azole antifungals, some macrolides, some HIV meds)

Risk: Higher quetiapine levels → more sedation, hypotension, and side effects; toxicity risk rises.

Action: Avoid or use specialist-guided dose reduction and close monitoring. If a strong inhibitor is unavoidable, reassess whether quetiapine is the right choice.

With: CYP3A4 inducers (example: carbamazepine, phenytoin, rifampin, St. John’s Wort)

Risk: Lower quetiapine levels → reduced efficacy and symptom breakthrough.

Action: Avoid if possible. If used together, expect reduced effect and need for careful reassessment (and possibly an alternative medication strategy).

With: Other sedatives (alcohol, benzodiazepines, opioids, sedating antihistamines, sleep meds)

Risk: Additive CNS depression → heavy sedation, impaired coordination, falls, and overdose risk (especially with opioids/alcohol).

Action: Minimize combinations. Avoid alcohol. Use the lowest effective doses and reassess daytime functioning and safety.

With: Blood pressure–lowering medications

Risk: More orthostatic hypotension, dizziness, and fainting.

Action: Go slow with titration, monitor orthostatics, and adjust the overall regimen if syncope/dizziness emerges.

With: QT-prolonging medications or electrolyte abnormalities

Risk: Higher QTc prolongation risk → rare but serious arrhythmias.

Action: Review QT risk before starting and after major dose changes; correct electrolytes; consider ECG monitoring in higher-risk patients.

With: Valproate

Risk: Reports suggest increased quetiapine exposure and higher rates of blood count abnormalities in some cases.

Action: Use thoughtfully, monitor side effects and CBC if clinically indicated, and reassess if excessive sedation or hematologic issues occur.

Pregnancy, Breastfeeding, Special Groups

Quetiapine can be used during pregnancy and breastfeeding in selected situations, but the decision should be individualized. The big themes are: use the lowest effective dose, avoid unnecessary polypharmacy, and monitor metabolic risks closely. In older adults, the dementia-related psychosis mortality warning is central and should shape decision-making.

👶Pregnancy

Quetiapine crosses the placenta. Large-class data for atypical antipsychotics do not show a clear major increase in congenital malformations overall, but individual outcome data vary and the safest plan depends on the psychiatric risk of relapse. Third-trimester exposure to antipsychotics can lead to newborn EPS and/or withdrawal symptoms (agitation, feeding issues, tone changes, respiratory distress, somnolence, tremor). Tapering late in pregnancy solely to reduce newborn symptoms is generally not recommended; instead, use the lowest effective dose and monitor. Quetiapine has meaningful metabolic risk; monitor for gestational diabetes as part of standard prenatal care.

🤱Breastfeeding

Quetiapine is present in breast milk, and published reports typically suggest very low relative infant doses. Breastfeeding is often considered acceptable when infant exposure is low, but infants should still be monitored for sedation, poor feeding, irritability, or developmental concerns—especially if premature, low birth weight, or if other sedatives are used. Use the lowest effective dose and avoid unnecessary medication combinations.

👧Children & Adolescents (Under 18)

Not approved for children younger than 10. For older children and teens, quetiapine may be used for specific severe psychiatric conditions in a comprehensive treatment program, with close monitoring for weight gain, metabolic effects, blood pressure changes and movement side effects.

👴Older Adults (65+)

High-risk medication in adults ≥65. Avoid for behavioral problems associated with dementia or delirium unless nonpharmacologic approaches failed and there is a risk of harm to self/others. If used, start low, titrate slowly, reassess often, and attempt deprescribing when appropriate. For labeled indications like schizophrenia or bipolar disorder, use may be appropriate but requires careful monitoring for falls, orthostasis, sedation, metabolic changes, hyponatremia/SIADH, and QT risk.

🔬Liver Impairment

Hepatic impairment reduces clearance and increases exposure. In cirrhosis, start very low (IR 25 mg once daily) and titrate gradually; avoid in severe cirrhosis when risk is high. Monitor liver biochemistries when clinically indicated; in cirrhosis, baseline and early follow-up labs are often recommended.

💧Kidney Impairment

No dosage adjustment is generally needed across degrees of kidney impairment; quetiapine is not significantly removed by dialysis.

Clinical Monitoring

Sedation and functional impairment: daytime sleepiness, reaction time, work/school performance; reassess after initiation and dose changes
Orthostatic vitals and fall risk: especially in older adults and during early titration; ask about dizziness, near-falls, fainting
Weight/BMI: baseline, early follow-up (weeks 8–12), then periodic monitoring; intervene early if rapid gain occurs
Metabolic labs: fasting glucose/HbA1c and lipid panel at baseline and follow-up (often around 3–4 months), then at least annually or more often if abnormal
Blood pressure and heart rate: monitor for tachycardia and BP changes; children and teens can show signs of hypertension
Movement side effects: akathisia, parkinsonism, dystonia, and tardive dyskinesia; use a standardized scale periodically (and more often if high risk)
ECG/QTc monitoring: as clinically indicated—baseline if risk factors; recheck after major dose increases or adding QT-prolonging meds
CBC: as clinically indicated, especially if low baseline WBC/ANC or history of drug-induced leukopenia/neutropenia
Liver function tests: baseline and follow-up when hepatic disease is present or if symptoms suggest liver injury; in cirrhosis, more structured monitoring early in treatment is often used
Thyroid labs (TSH/T4): if symptoms suggest thyroid changes or if clinically indicated
Mental status and safety: suicidality monitoring (especially in younger patients when used in depression contexts), worsening agitation, emerging mania, psychosis relapse signals
Hyponatremia/SIADH risk in older adults: consider sodium monitoring with initiation and dose adjustments in higher-risk patients

How Well It Works

Quetiapine is a core medication in several psychiatric conditions: schizophrenia and bipolar disorder (including bipolar depression), and it’s also used as an add-on option for major depression. Off-label, it may help anxiety or insomnia in select cases—but the benefit often comes from sedation, and that’s not free. The goal is symptom relief with tolerable side effects: stable mood without metabolic harm, psychosis control without disabling daytime sedation, and sleep help without turning the next day into a fog.

Source:

Mechanism of Action

Quetiapine is an atypical antipsychotic that works by blocking (antagonizing) several brain receptors. The core antipsychotic effect is thought to come from a mix of dopamine (D2) and serotonin (5-HT2) blockade. It also blocks histamine (H1) and alpha-1 receptors, which helps explain why it can cause heavy sedation and orthostatic dizziness. Its active metabolite (norquetiapine) has additional receptor effects that may contribute to mood and side effects (including more anticholinergic-type symptoms in some people).

Place in Treatment Algorithm

Quetiapine is a first-line or core option in bipolar disorder (including bipolar depression) and a standard option for schizophrenia. In major depression, it’s usually considered when a person has had an inadequate response to antidepressants alone (as an add-on). Off-label use for anxiety or insomnia can be reasonable in select cases—especially when there’s bipolar disorder or significant agitation in the picture—but it’s not a casual sleep med. If the main goal is sleep and the person doesn’t have a strong psychiatric indication, the metabolic and cardiovascular tradeoffs often outweigh the benefit.

Questions people ask

What is quetiapine (Seroquel) used for?

Quetiapine is used for schizophrenia and bipolar disorder (mania and bipolar depression). It can also be used as an add-on for major depression when an antidepressant alone isn’t enough. Off-label, it’s sometimes used for anxiety or insomnia in select cases—usually when there’s a psychiatric reason that makes the risk/benefit make sense.

Why does Seroquel make people so sleepy?

Quetiapine strongly blocks histamine (H1) receptors, which can cause heavy sedation—especially at lower-to-moderate doses and early in treatment. For some people, that’s the point (sleep), but for others it becomes the reason they quit (daytime fog, oversleeping).

Is Seroquel addictive?

It’s not a controlled substance and it doesn’t cause the classic addiction pattern like benzodiazepines or opioids. But your body can adapt to it, and stopping abruptly can cause rebound insomnia, anxiety, agitation, and symptom return. So it’s not “no consequences”—it’s more “not a drug of abuse in the usual way.”

Does quetiapine cause weight gain?

Yes, it can. Quetiapine is known for increasing appetite and causing weight gain in a meaningful number of people, and it can also worsen triglycerides, cholesterol, and blood sugar. This is why baseline and follow-up metabolic monitoring isn’t optional—it’s part of safe prescribing.

Can quetiapine raise blood sugar or cause diabetes?

It can raise blood sugar and increase the risk of new-onset diabetes in some people, especially with longer exposure and with other risk factors. Monitoring fasting glucose or HbA1c (and acting early if numbers change) is how you reduce harm.

Is quetiapine safe in older adults?

It depends on why it is being used. In older adults with dementia-related psychosis, antipsychotics increase the risk of death, and quetiapine is not approved for that use. For conditions like schizophrenia or bipolar disorder, it may still be used in older adults, but usually at lower doses, raised more slowly, with closer checks for falls, low blood pressure, sleepiness and metabolic changes.

Does Seroquel prolong QT or cause heart rhythm problems?

Quetiapine can cause a heart-rhythm change seen on an ECG (QTc prolongation) that can be dangerous. The risk grows with dose and is usually modest, but it can become important in people with risk factors (an already long QT, low potassium or magnesium, heart disease, interacting medicines, overdose). If you have had fainting or a pounding or racing heartbeat, or you take other medicines that affect QT, ask about ECG checks.

Can I use Seroquel just for sleep?

Sometimes—but it’s not a casual sleep med. If you have bipolar disorder, severe anxiety, or another psychiatric condition where quetiapine is pulling double duty, sleep benefit may be part of the plan. If the only problem is insomnia, the metabolic and cardiovascular tradeoffs often outweigh the benefit, especially long-term.

How do I stop quetiapine safely?

Most people should taper rather than stop suddenly, especially after long-term use. Lowering the dose gradually helps avoid rebound insomnia or anxiety and lets you catch early signs of relapse. If you are stopping because of a serious side effect, get a clinician's guidance urgently.

Is quetiapine safe in pregnancy or breastfeeding?

It can be used in pregnancy or breastfeeding when clinically indicated, but it should be individualized. In pregnancy, the big issues are relapse risk if you stop treatment and metabolic monitoring (including gestational diabetes screening as part of routine prenatal care). In breastfeeding, reported infant exposure is generally low, but infants should be monitored for sedation or feeding issues—especially if premature or if other sedatives are involved.